Postvaccination thrombocytopenia in Canada

Pediatric Infectious Disease Journal

Volumn 29, Issue 6, 2010, Pages 559-561

  Sauvé, Laura J ^a   Bettinger, Julie ^a   Scheifele, David ^a   Halperin, Scott ^b   Vaudry, Wendy ^c   Law, Barbara ^d  

^a BC CHILDREN S HOSPITAL   (Canada)

^b IWK HEALTH CENTRE   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Adverse events following immunization; Measles vaccine; Thrombocytopenia

Indexed keywords

BETA LACTAM ANTIBIOTIC; CHICKENPOX VACCINE; CORTICOSTEROID; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PHENOBARBITAL; SULFONAMIDE; VACCINE;

ARTICLE; BLEEDING; CHICKENPOX; CHILD; CONTROLLED STUDY; DIPHTHERIA; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEASLES; MENINGOCOCCOSIS; MUMPS; PEDIATRIC HOSPITAL; PERTUSSIS; PRIORITY JOURNAL; RUBELLA; TERTIARY HEALTH CARE; TETANUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VACCINATION REACTION; CANADA; HEALTH CARE QUALITY; IMMUNIZATION; INFANT; PRESCHOOL CHILD; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; VACCINATION;

CANADA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUALITY ASSURANCE, HEALTH CARE; VACCINATION; VACCINES;

EID: 77953160268     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181d2bb45     Document Type: Article

References (16)

1. France EK, Glanz JM, Xu S, et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008;121:e687-e692.
2. Miller E, Waight P, Farrington CP, et al. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child. 2001;84:227-229.
3. Black C, Kaye JA, Hershel J. MMR vaccine and idiopathic thrombocyto-paenic purpura. Br J Clin Pharmacol. 2003;55:107-111.
4. Rajantie J, Zeller B, Treutiger I, et al. Vaccination associated thrombocy-topenic purpura in children. Vaccine. 2007;25:1838-1840.
5. Jadavji T, Scheifele D, Halperin S, et al. Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr Infect Dis J. 2003;22: 119-122.
6. Statistics Canada. Statistics Canada Website. Available at: http://www. statcan.gc.ca/start-debut-eng.html. Accessed October 26, 2009.
7. Public Health Agency of Canada. Canadian national report on immunization, 2006. Can Commun Dis Rep. 2006;32 S3:1-44.
8. Gustafson R, Skowronski DM. Disparities in varicella vaccine coverage in the absence of public funding. Vaccine. 2005;23:3519-3525.
9. Wise RP, Bonhoeffer J, Beeler J, et al. Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25:5717-5724. (Pubitemid 47049766)
10. Jonville-Bera AP, Autret EM, Galy-Eyraud CM, et al. Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-merieux serums et vaccins. Pediatr Infect Dis J. 1996;15:44-48.
11. Angelini PM, Kavadas FM, Sharma NM, et al. Aplastic anemia following varicella vaccine. Pediatr Infect Dis J. 2009;28:746-748.
12. Rivest P, Bédard L, Valiquette L, et al. Severe complications associated with varicella: province of Quebec, April 1994 to March 1996. Can J Infect Dis Med Microbiol. 2001;12:21-26.
13. Stratton KR, Howe CJ, Johnston SL Jr, eds. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: Institute of Medicine; 1994.
14. Beeler J, Varricchio F, Wise R. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). Pediatr Infect Dis J. 1996;15:88-90.
15. Oski FA, Naiman JL. Effect of live measles vaccine on the platelet count. N Engl J Med. 1966;275:352-356.
16. Stowe J, Kafatos G, Andrews N, et al. Idiopathic thrombocytopenic purpura and the second dose of MMR. Arch Dis Child. 2008;93:182-183.